Abstract:Key PointsApoptosis and autophagy constitute the two self-destructive processes by which supernumerary, damaged or aged cells and organelles are eliminated. Beyond this homeostatic function, autophagy is also a process through which cells adapt their metabolisms to starvation, imposed by decreased extracellular nutrients or by decreased intracellular metabolite concentrations that result from growth-factor signalling.The relationship between autophagy and cell death is complex because autophagy constitutes an adaptive response to different kinds of stress by which the cells avoid cell death; yet, in some settings, it can also contribute to the demise of cells.In response to the same panoply of stressors, cells can preferentially undergo apoptosis or autophagy, a choice that is dictated by the intensity of the stimulus and thresholds for either response. Several stress mediators (reactive oxygen species, ceramide, elevation of cytosolic Ca2+), isoforms of p19ARF (or its human homologue, p14ARF), p53, BH3-only proteins and death-associated protein kinases (DAPK family members) can stimulate both apoptosis and autophagy.Organellar stress that affects mitochondria and the endoplasmic reticulum can induce a specific autophagic response that leads to the removal of damaged organelles (mitophagy and reticulophagy, respectively) and protects cells. Beyond a threshold (which is lowered when autophagy is inhibited), such stress causes apoptosis.Several proteins that have an essential role in autophagy have a direct or indirect impact on the regulation or execution of apoptosis. As an example, Atg5 is an essential autophagy inducer, yet it can be cleaved by calpain cysteine proteases to lose its pro-autophagy effects and become a pro-apoptotic molecule.Beclin-1 (or its yeast homologue Atg6) interacts with the anti-apoptotic multidomain proteins of the BCL2 family (in particular BCL2 and BCL-XL) through a BH3 domain. BH3-only proteins and pharmacological BH3 mimetics competitively disrupt the inhibitory interaction between beclin-1 and BCL2 or BCL-XL, thereby stimulating autophagy. Thus, BH3 domains, which are well known for their apoptosis-inducing property, can also stimulate autophagy.The pharmacological stimulation of autophagy may have cytoprotective effects, for example, in mouse models of neurodegenerative disease, whereas the inhibition of autophagy can sensitize cancer cells to chemotherapy to promote p53-induced apoptosis. Thus, manipulation of autophagy can determine cell-fate decisions in clinical settings.

Crosstalk between apoptosis, necrosis and autophagy

Interplay Between Apoptosis and Autophagy in Colorectal Cancer

The molecular relationships between apoptosis, autophagy and necroptosis

Necroptosis in Inflammatory Bowel Disease and Other Intestinal Diseases

The Interplay Between Autophagy and Regulated Necrosis

Caspases: a Molecular Switch Node in the Crosstalk Between Autophagy and Apoptosis.

Cell death pathways: intricate connections and disease implications

Crosstalk Between Autophagy And Apoptosis: Potential And Emerging Therapeutic Targets For Cardiac Diseases

The Critical Molecular Interconnections in Regulating Apoptosis and Autophagy

Deciphering the Molecular Nexus: an In-Depth Review of Mitochondrial Pathways and Their Role in Cell Death Crosstalk

Self-eating and self-killing: crosstalk between autophagy and apoptosis

Crosstalk of autophagy and apoptosis: Involvement of the dual role of autophagy under ER stress

Autophagy as a modulator of cell death machinery

Cell death: a review of the major forms of apoptosis, necrosis and autophagy

ROS, Cathepsins, and Their Interplay in Cell Death and Autophagy

Autophagy and Tumor Cell Death

Programmed necrosis in the cross talk of cell death and inflammation.

Mediators of necroptosis: from cell death to metabolic regulation

The Role of Autophagy in Cell Death

Autophagy and cell death in model organisms

The Crosstalk of Apoptotic and Non-Apoptotic Signaling in CD95 System